ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BIO Bio Rad Laboratories Inc

293.39
-6.88 (-2.29%)
Last Updated: 18:08:12
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bio Rad Laboratories Inc NYSE:BIO NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -6.88 -2.29% 293.39 299.94 291.48 296.18 119,227 18:08:12

Specialized Disclosure Report (sd)

24/05/2023 9:51pm

Edgar (US Regulatory)




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM SD
SPECIALIZED DISCLOSURE REPORT


BIO-RAD LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

Commission File Number: 1-7928
 
Delaware 94-1381833
(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)
 
1000 Alfred Nobel Dr.
Hercules, California 94547
(Address of principal executive offices, including zip code)
 
Timothy S. Ernst
(510)741-6005
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2022.





Section 1 - Conflict Minerals Disclosure

Item 1.01 Conflict Minerals Disclosure and Report

Bio-Rad Laboratories, Inc. (the “Company”) evaluated its current product lines and determined that tin, tungsten, tantalum and gold (“3TG”) are necessary to the functionality or production of certain products manufactured by the Company or contracted by the Company to be manufactured and are required to be reported in the calendar year covered by this specialized disclosure report. Accordingly, the Company conducted in good faith a reasonable country of origin inquiry regarding the 3TG in our products that was reasonably designed to determine whether any such 3TG originated in the Democratic Republic of the Congo or an adjoining country or were from recycled or scrap sources.

Conflict Minerals Disclosure

Based on our reasonable country of origin inquiry, we have filed a Conflict Minerals Report, which is attached hereto as Exhibit 1.01 and is publicly available at the Investor Relations section of our website under the heading Corporate Governance: https://www.bio-rad.com/en-us/corporate/corporate-governance?ID=NEUKYV15. The content of our website referred to in this Form SD is included for general information and is not incorporated by reference in this Form SD.

Item 1.02 - Exhibit

See Exhibit 1.01 attached hereto.

Section 2 - Exhibits












SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereto duly authorized.


                             BIO-RAD LABORATORIES, INC.
                                                                             (Registrant)
Date:May 24, 2023/s/ Timothy S. Ernst
Timothy S. Ernst
EVP, General Counsel and Secretary


1 Year Bio Rad Laboratories Chart

1 Year Bio Rad Laboratories Chart

1 Month Bio Rad Laboratories Chart

1 Month Bio Rad Laboratories Chart